Nelson Jamel has resigned from his positions as a non-executive director and a member of the Audit and Risk Committee to pursue other opportunities. Fernando Tennenbaum has been appointed as a non-executive director and a member of the Audit and Risk Committee. Furthermore, John Blood, David Almeida, and Katherine Barrett will each cease to serve as alternate directors for Mr. Jamel and will be appointed as alternate directors for Mr. Tennenbaum, with all changes effective from January 1, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments